Continue to site >
Trending ETFs

Name

As of 06/01/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$29.18

$1 M

0.11%

$0.03

0.49%

Vitals

YTD Return

N/A

1 yr return

N/A

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$1 M

Holdings in Top 10

32.3%

52 WEEK LOW AND HIGH

$28.6
$22.40
$29.18

Expenses

OPERATING FEES

Expense Ratio 0.49%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 06/01/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$29.18

$1 M

0.11%

$0.03

0.49%

QFRD - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.1%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    Pacer S&P 500 Quality FCF R&D Leaders ETF
  • Fund Family Name
    N/A
  • Inception Date
    Jan 13, 2026
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US

Fund Description

The Fund employs a “passive management” (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the Index.
The Index
The Index uses an objective, rules-based methodology to provide exposure to 50 stocks within the S&P 500 Index® (the “S&P 500”) that exhibit high research and development (R&D) Intensity while maintaining higher than median free cash flow (FCF) margin and FCF return on invested capital (ROIC). S&P Dow Jones Indices LLC (the “Index Provider”) compiles, maintains and calculates the Index.
The Index’s initial universe is derived from the component companies of the S&P 500. The S&P 500 is comprised of common stocks of approximately 500 large-capitalization companies that generally represent the large-cap segment of the U.S. equity market.
Free Cash Flow (FCF): net cash flow from operating activities minus capital expenditures
FCF Margin: FCF / revenue
FCF ROIC: FCF / (total debt plus total equity)
R&D Intensity: R&D expense / sales
The Index’s initial universe of companies is screened based on a company’s FCF margin and FCF ROIC. To be considered for inclusion in the Index, a company must be in the top 50% of securities by FCF Score, which is calculated using the five-year average of company’s FCF Margin and the five-year average of the company’s FCF ROIC. Companies classified as being in the real estate sector and companies classified as being in certain industries within the financials sector (banks, asset management & custody banks, investment banking & brokerage, specialized finance, insurance) are excluded from the Index universe.
The remaining companies are then ranked by their R&D Intensity Score, which is calculated using the five-year average of R&D expense divided by sales (i.e., R&D Intensity). The 50 companies with the highest R&D Intensity Scores are included in the Index. The constituents are weighted in descending order by their R&D Intensity Score, with the maximum weight of each constituent capped at 4.5%.
Weight above the individual security cap are typically redistributed among the other Index constituents in proportion to their weights. As of October 31, 2025, the companies included in the Index had a market capitalization range of $11.5 billion and $4.9 trillion. As of October 31, 2025, the Index had significant exposure to the information technology and health care sectors.
The Index is typically reconstituted and rebalanced semi-annually as of the close of business on the third Friday of April and October based on data as of the last business days of March and September, respectively. The Index is also reviewed semi-annually in January and July based on each constituent’s weight; recapping is performed if the aggregate weight of constituents with an individual weight greater than 4.8% exceeds 24% of the Index’s total weight. If that threshold is breached, the current constituent weights are recapped, with the weights of individual constituents capped at 10% and the aggregate weight of constituents with an individual weight greater than 4.5% capped at 22.5% of the Index’s total weight.
The Fund’s Investment Strategy
Under normal circumstances, at least 80% of the Fund’s net assets (plus any borrowings for investment purposes) will be invested in equity securities that are the component securities of the Index. The Fund defines “equity securities” to mean common stocks, and may include preferred stocks, rights, warrants, and depositary receipts. The Adviser expects that, over time, the correlation between the Fund’s performance and that of the Index, before fees and expenses, will be 95% or better.
The Fund will generally use a “replication” strategy to achieve its investment objective, meaning it will invest in all of the component securities of the Index in the same approximate proportion as in the Index.
The Fund is non-diversified and therefore may invest a larger percentage of its assets in the securities of a single company than diversified funds.
To the extent the Index concentrates (i.e., holds more than 25% of its total assets) in the securities of a particular industry or group of related industries, the Fund will concentrate its investments to approximately the same extent as the Index. As of October 31, 2025, the Index was not concentrated in any industry or group of industries.
Read More

QFRD - Performance

Return Ranking - Trailing

Period QFRD Return Category Return Low Category Return High Rank in Category (%)
YTD N/A N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Return Ranking - Calendar

Period QFRD Return Category Return Low Category Return High Rank in Category (%)
2025 N/A N/A N/A N/A
2024 N/A N/A N/A N/A
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A

Total Return Ranking - Trailing

Period QFRD Return Category Return Low Category Return High Rank in Category (%)
YTD N/A N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Total Return Ranking - Calendar

Period QFRD Return Category Return Low Category Return High Rank in Category (%)
2025 N/A N/A N/A N/A
2024 N/A N/A N/A N/A
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A

QFRD - Holdings

Concentration Analysis

QFRD Category Low Category High QFRD % Rank
Net Assets 1 M N/A N/A N/A
Number of Holdings 51 N/A N/A N/A
Net Assets in Top 10 310 K N/A N/A N/A
Weighting of Top 10 32.29% N/A N/A N/A

Top 10 Holdings

  1. Incyte Corp 3.71%
  2. Vertex Pharmaceuticals Inc 3.62%
  3. Merck Co Inc 3.52%
  4. Regeneron Pharmaceuticals Inc 3.40%
  5. Synopsys Inc 3.39%
  6. Electronic Arts Inc 3.19%
  7. Cadence Design Systems Inc 2.97%
  8. Biogen Inc 2.96%
  9. Airbnb Inc 2.78%
  10. Datadog Inc 2.75%

Asset Allocation

Weighting Return Low Return High QFRD % Rank
Stocks
99.94% N/A N/A N/A
Cash
0.06% N/A N/A N/A
Preferred Stocks
0.00% N/A N/A N/A
Other
0.00% N/A N/A N/A
Convertible Bonds
0.00% N/A N/A N/A
Bonds
0.00% N/A N/A N/A

Stock Sector Breakdown

Weighting Return Low Return High QFRD % Rank
Utilities
0.00% N/A N/A N/A
Technology
0.00% N/A N/A N/A
Real Estate
0.00% N/A N/A N/A
Industrials
0.00% N/A N/A N/A
Healthcare
0.00% N/A N/A N/A
Financial Services
0.00% N/A N/A N/A
Energy
0.00% N/A N/A N/A
Communication Services
0.00% N/A N/A N/A
Consumer Defense
0.00% N/A N/A N/A
Consumer Cyclical
0.00% N/A N/A N/A
Basic Materials
0.00% N/A N/A N/A

Stock Geographic Breakdown

Weighting Return Low Return High QFRD % Rank
US
99.94% N/A N/A N/A
Non US
0.00% N/A N/A N/A

QFRD - Expenses

Operational Fees

QFRD Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.49% N/A N/A N/A
Management Fee 0.49% N/A N/A N/A
12b-1 Fee N/A N/A N/A N/A
Administrative Fee N/A N/A N/A N/A

Sales Fees

QFRD Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A N/A N/A N/A
Deferred Load N/A N/A N/A N/A

Trading Fees

QFRD Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A N/A N/A N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

QFRD Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A N/A N/A N/A

QFRD - Distributions

Dividend Yield Analysis

QFRD Category Low Category High QFRD % Rank
Dividend Yield 0.11% N/A N/A N/A

Dividend Distribution Analysis

QFRD Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly

Net Income Ratio Analysis

QFRD Category Low Category High QFRD % Rank
Net Income Ratio N/A N/A N/A N/A

Capital Gain Distribution Analysis

QFRD Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Distributions History

View More +

QFRD - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
N/A N/A N/A N/A